Clinicaltrialvanguard

Published October 16, 2026

Edesa Biotech Clears IND for Phase 2 EB06 Study in Vitiligo - The Clinical Trial Vanguard

Read the full story at Clinicaltrialvanguard

Edesa Biotech wins FDA clearance to advance EB06, a CXCL10 ... Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site.